PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo; President: Jiro Sugimoto) has successfully developed a novel synthetic ...

Few treatments can compete with lasers for targeting fine lines, wrinkles, and other skin texture concerns. Fractional lasers ...

Event: 2024 Cell & Gene Meeting on the Mesa Session Date and Time: October 7, 2024, at 5:45 p.m. MST Location: FLW Ballroom F For more information, please visit FibroBiologics' website or email ...

As people age, more patients are developing heart failure. A study from Nagoya University found that an enzyme called PKN is ...

Zhejiang Doer Biologics Co., Ltd. ('Doer Bio'), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its ...

“While all dermatologists treat hair, skin and nails, finding someone who has special training and interest in skin of color ...

Salmon sperm facials, otherwise known as polynucleotides, have come to the forefront as the future of aesthetic treatments - ...

Pete O'Heeron, Founder and Chief Executive Officer of FibroBiologics, said, "This engagement is an important step forward in creating the infrastructure for FibroBiologics to conduct clinical trials ...

“Our ongoing exploration of therapeutic applications using fibroblast cells continues to provide unique opportunities for our platform,” commented founder & CEO of FibroBiologics, Pete O’Heeron. “This ...

The enzyme catalyzes the conversion of heart fibroblasts to myofibroblasts, which threatens the integrity of the heart. The heart uses small cells known as fibroblasts to maintain its integrity ...